The BA400 clinical chemistry and turbidimetry analyser offers excellent performance to laboratories looking towards achieving highest efficiency with optimal operative cost. It has been designed to provide high operating autonomy, through its high capacity for samples (135; 90 with direct barcode reading) and reagents (88 positions) and capability to operate up to 9 hours of continuous working without refilling/voiding the system’s reservoirs. The BA400 incorporates proprietary LED technology for the optical system, with virtually no maintenance and without optical interferences. It uses a battery of high power LED monochromatic sources with 8 working wavelengths covering the most demanding methods of routine and specific chemistry. Maintenance is simplified using distributed electronics through CAN (Controller Area Network) bus system, thus significantly optimizing performance and reducing down times; low mechanical wear dispensing pumps with ceramic piston are capable of operating up to 5 millions cycles. The analyser is also equipped with an independent powered reagents cooling system to ensure on board stability
Read more

Legionella pneumophila is responsible for at least two diseases in humans: Legionnaires’ disease, which is a severe form of pneumonia, clinically indistinguishable from other types of bacterial pneumonia, and Pontiac fever which is a flu-like illness. Legionella pneumophila is often associated with systemic manifestations and is responsible for up to 10% of hospitalized pneumonia cases acquired in the community. Statens Serum Institut has developed Immuview® Legionella Blood Test which is a lateral flow test for identification of IgM against Legionella pneumophila serogroup 1 and 3. It has been developed as a test primarily for patients with severe pneumonia; who have travelled abroad or been in areas with outbreak of Legionella; who have had indications of Legionella in a urine test; who have caught pneumonia when hospitalized. The Immuview® Legionella Blood test makes it possible to identify IgM antibodies against Legionella pneumophila serogroup 1 and 3 early in the course of the illness, and at the stage when the patient is normally admitted to the hospital. The test contains Legionella pneumophila serogroup 1 and 3 antigens, which have been applied to a lateral flow membrane. The test is simple to use and shows a result within 20 minutes. A drop of blood is added to the sample port, and a minute later four drops of running buffer is added to the buffer addition port. After 20 minutes the result can be read. ImmuView™ Legionella Blood Test is sold in kits of 10 or 50 tests including buffer, a positive control, and a score card for semi quantitative measuring.
Read more

Cryptosporidium and Giardia are the first two products in the Uni-Gold Enterics Rapids range of single use immunoassays for the qualitative detection of pathogenic antigens. The Uni-Gold Cryptosporidium and Uni-Gold Giardia are both CE marked tests. They feature an even more rapid and simple sample preparation, convenient storage and a 4-step device procedure, giving accurate results within 15 minutes. Developed for easy and accurate detection of enteric pathogens, the Uni-Gold rapids provide convenience and high quality.  

Read more

The hormone 1,25 dihydroxy vitamin D is formed in the kidney and has important functions in calcium metabolism; hence impaired kidney function can result in a decrease in 1,25 dihydroxy vitamin D levels and the development of renal osteopathy, which is characterized by osteomalacia and osteitis fibrosa. This company’s assay development programme is focusing specifically on new vitamin D assays. After the recent launch of the 25-Hydroxyvitamin D Total RIA and ELISA assays based on patented monoclonal antibodies manufactured in-house, a new easy-to-use 1,25 dihydroxy Vitamin D ELISA is launched. This ELISA is specifically designed to be used manually as well as on open automated systems. As the total assay time is less than 6 hours, the patient’s results will be available the same day. The assay has been validated on the Stratec GEMINI open ELISA automated analyser (Stratec Biomedical GMBH – Germany) and a validated protocol will be made available to all Stratec GEMINI users.
Read more

Helicobacter pylori (H. pylori) is a cork-screw-spiral-like gram-negative bacterium that has adapted to grow in the human stomach. The prevalence of H. pylori infection worldwide is approximately 66%, and in developing countries, it is as high as 80% – 90%. The testing and treatment of H. pylori is very important as it has been estimated that up to 20% of people infected with H. pylori will develop ulcers which may lead to specific cancers. MP Diagnostics ASSURE H. pylori Rapid Test and Helico Blot 2.1 Western Blot incorporate a unique marker, CIM, which is used to detect the current infection of H. pylori bacteria. CIM stands for Current Infection Marker which is actually a H. pylori-specific protein. The nucleotide sequence of the CIM antigen is homologous to a conserved secreted protein. This protein has been found to be highly immunogenic for detection of H. pylori infected patients with high Positive Predictive Value of >90%. It has been coined as Current Infection Marker because IgG antibodies for CIM have been found in patients with active H. pylori infection. These patients are confirmed to have active H. pylori infection by two or more active infection diagnostic tests such as rapid urease test, culture, histology, and Urea Breath Test. With CIM-based products, no additional tests are needed for detecting current H. pylori infection.
Read more